1. Home
  2. TBRG vs GBIO Comparison

TBRG vs GBIO Comparison

Compare TBRG & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TBRG
  • GBIO
  • Stock Information
  • Founded
  • TBRG 1979
  • GBIO 2016
  • Country
  • TBRG United States
  • GBIO United States
  • Employees
  • TBRG N/A
  • GBIO N/A
  • Industry
  • TBRG
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • TBRG
  • GBIO Health Care
  • Exchange
  • TBRG NYSE
  • GBIO Nasdaq
  • Market Cap
  • TBRG 271.5M
  • GBIO 64.8M
  • IPO Year
  • TBRG N/A
  • GBIO 2020
  • Fundamental
  • Price
  • TBRG $21.27
  • GBIO $0.88
  • Analyst Decision
  • TBRG Buy
  • GBIO Strong Buy
  • Analyst Count
  • TBRG 3
  • GBIO 2
  • Target Price
  • TBRG $14.67
  • GBIO $6.50
  • AVG Volume (30 Days)
  • TBRG 78.7K
  • GBIO 581.0K
  • Earning Date
  • TBRG 02-27-2025
  • GBIO 03-05-2025
  • Dividend Yield
  • TBRG N/A
  • GBIO N/A
  • EPS Growth
  • TBRG N/A
  • GBIO N/A
  • EPS
  • TBRG N/A
  • GBIO N/A
  • Revenue
  • TBRG $337,674,000.00
  • GBIO $18,582,000.00
  • Revenue This Year
  • TBRG $1.02
  • GBIO $212.74
  • Revenue Next Year
  • TBRG $6.06
  • GBIO N/A
  • P/E Ratio
  • TBRG N/A
  • GBIO N/A
  • Revenue Growth
  • TBRG 0.26
  • GBIO 514.08
  • 52 Week Low
  • TBRG $7.55
  • GBIO $0.75
  • 52 Week High
  • TBRG $21.80
  • GBIO $4.65
  • Technical
  • Relative Strength Index (RSI)
  • TBRG 74.93
  • GBIO 28.66
  • Support Level
  • TBRG $20.62
  • GBIO $0.85
  • Resistance Level
  • TBRG $21.80
  • GBIO $1.01
  • Average True Range (ATR)
  • TBRG 0.72
  • GBIO 0.12
  • MACD
  • TBRG 0.08
  • GBIO 0.00
  • Stochastic Oscillator
  • TBRG 85.87
  • GBIO 7.50

About TBRG TRUBRIDGE INC

TruBridge Inc is a provider of healthcare solutions and services for community hospitals, clinics, and other healthcare systems. It provides services such as Electronic health records & information systems, revenue cycle management, population health, and data management, etc. The segments of the company are RCM, EHR, and Patient Engagement. The company derives maximum revenue from the RCM segment.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: